Expertise in
3
conditions

Kouji Joko

Matsuyama, JP 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
3
conditions
Matsuyama, JP 
OverviewLocationsClinical Research

Overview

Kouji Joko practices in Matsuyama, Japan. Joko is highly rated in 3 conditions, according to our data. Their top areas of expertise are Liver Cancer, Hepatitis C, Hepatitis, Pancreaticoduodenectomy, and Hepatectomy.

Their clinical research consists of co-authoring 84 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.

Locations

Matsuyama, 7908524, Japan
Other Locations
Toyama, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Prospective, Multi-Centre Study (B-Sure) to Evaluate Long-Term Durability of Treatment Response in Chronic Hepatitis B Participants With and Without Nucleos(t)Ide Therapy Who Have Participated in a Previous Bepirovirsen Treatment Study
A Prospective, Multi-Centre Study (B-Sure) to Evaluate Long-Term Durability of Treatment Response in Chronic Hepatitis B Participants With and Without Nucleos(t)Ide Therapy Who Have Participated in a Previous Bepirovirsen Treatment Study
Enrollment Status: Recruiting
Publish Date: April 10, 2025
Intervention Type: Drug
Study Drug: GSK3228836
Study Phase: Phase 2
Phase IIb Multi-Center, Randomised, Partial-Blind Parallel Cohort Study to Assess the Efficacy and Safety of Treatment With GSK3228836 in Participants With Chronic Hepatitis B Virus (B-Clear)
Phase IIb Multi-Center, Randomised, Partial-Blind Parallel Cohort Study to Assess the Efficacy and Safety of Treatment With GSK3228836 in Participants With Chronic Hepatitis B Virus (B-Clear)
Enrollment Status: Completed
Publish Date: May 16, 2023
Intervention Type: Drug
Study Drugs: GSK3228836, Nucleos(t)ide therapy
Study Phase: Phase 2
View 1 Less Clinical Trial

84 Total Publications

Simple new clinical score to predict hepatocellular carcinoma after sustained viral response with direct-acting antivirals.
Simple new clinical score to predict hepatocellular carcinoma after sustained viral response with direct-acting antivirals.
Journal: Scientific reports
Published: February 21, 2023

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Joko's expertise for a condition
ConditionClose
    View All 10 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile